{"top_spans": [[0, 2], [6, 6], [10, 16], [17, 17], [19, 19], [21, 21], [22, 25], [22, 27], [27, 27], [30, 31], [30, 33], [32, 33], [35, 35], [36, 37], [36, 41], [36, 42], [39, 39], [41, 41], [42, 42], [47, 47], [49, 55], [59, 64], [66, 66], [68, 68], [70, 70], [71, 74], [76, 76], [76, 79], [78, 79], [80, 80], [80, 83], [80, 85], [81, 85], [84, 84], [84, 85], [86, 86], [87, 92]], "predicted_antecedents": [-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 18, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1], "document": ["bristol", "-", "myers", "inks", "deal", "and", "invests", "12", "million", "in", "compugen", "bristol", "-", "myers", "squibb", "company", "bmy", "announced", "that", "it", "has", "entered", "a", "clinical", "trial", "collaboration", "with", "compugen", "cgen", "per", "the", "deal", "the", "companies", "will", "evaluate", "the", "safety", "and", "tolerability", "of", "compugen", "com701", "an", "investigational", "antibody", "in", "combination", "with", "bristol", "-", "myers", "immune", "checkpoint", "inhibitor", "opdivo", "in", "patients", "with", "advanced", "solid", "tumors", "bristol", "-", "myers", "also", "announced", "that", "it", "will", "make", "a", "12-million", "equity", "investment", "in", "compugen", "purchasing", "solid", "tumors", "compugen", "12", "12", "million", "united", "states", "compugen", "cgen", "eu", "opdivo", "bristol", "-", "myers"], "clusters": [[[19, 19], [68, 68]]]}